Phio pharmaceuticals corp. (PHIO)
CashFlow / Quarterly
Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Jun'12Mar'12
Cash flows from operating activities:
Net loss

-2,660

-2,094

-2,035

-2,119

-1,727

-1,493

-1,901

-2,239

-2,002

-2,476

-2,514

-5,460

-2,616

-2,496

-2,166

-2,945

-2,304

-2,206

-2,006

-2,284

-2,508

-2,059

-1,961

-14,397

-7,598

-1,926

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization

16

15

18

18

20

20

21

20

22

21

16

11

17

19

20

21

19

26

20

22

21

25

27

26

39

40

Gain on disposal of property and equipment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

Non-cash lease expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

Accretion and receipt of bond discount

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

Non-cash stock-based compensation expense

31

47

62

160

165

39

37

41

38

43

119

114

292

385

447

411

444

454

457

491

473

449

429

628

160

214

Fair value of common stock warrants issued in exchange for services

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

Acquired in-process research and development

-

-

-

-

-

-

-

-

0

0

85

4,611

0

0

0

228

-

-

-

-

0

0

0

12,250

-

-

Deferred taxes

-

-

-

-

-

-

-

-

0

0

0

-1,621

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Fair value of Parent Company's shares mandatorily redeemable for cash upon exercise of warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

Fair value of Parent Company's common stock and common stock warrants issued in exchange for services

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

Change in fair value of derivatives of Parent Company issued in connection with various equity financings

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

Loss on exchange of equity instruments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

Fair value of Parent Company common stock issued in exchange for licensing rights

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

Changes in operating assets and liabilities:
Prepaid expenses and other assets

-217

26

390

-86

-111

-127

253

-13

-70

-66

212

-25

-

-

-

-

-68

143

141

-77

122

-28

105

-110

104

-128

Right of use asset

-

-

-

-28

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-91

-

-

-

-

-

-

-

-

-

-

Accounts payable

-47

120

15

171

59

-51

21

10

-191

-39

69

-447

941

-413

176

174

148

-156

16

114

-14

-181

-8

-50

-470

360

Due to former parent

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

Accrued expenses and other liabilities

-106

-55

395

-491

-374

-649

215

248

-147

188

120

-32

-337

256

90

95

44

276

-342

-771

777

105

200

-54

-226

-6

Lease Liability

-24

-25

-25

-28

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-47

-14

-17

-11

-29

-29

-92

-638

359

-30

-19

Net cash used in operating activities

-

-

-

-

-

-

-

-

-

-

-

-2,799

-1,582

-1,963

-1,800

-1,972

-1,595

-1,766

-2,017

-2,380

-

-

-

-

-

-

Net cash used in operating activities

-2,546

-1,991

-1,933

-2,175

-1,746

-2,007

-1,860

-1,907

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-1,128

-1,446

-1,209

Cash flows from investing activities:
Change in restricted cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

Purchase of short-term investments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

9,000

0

-

-

Maturities of short-term investments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

Cash acquired in MirImmune Inc. acquisition

-

-

-

-

-

-

-

-

0

0

0

100

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cash paid for purchase of property and equipment

-5

61

15

1

5

0

0

0

0

15

186

2

18

0

31

8

-

-

-

-

68

8

2

0

-

-

Proceeds from disposal of property and equipment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

Cash paid for lease deposit

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

Net cash provided by investing activities

-

-

-

-

-

-

-

-

-

-

-

98

2,482

0

-8,031

-8

-

-

-

-

-

-

-

-

-

-

Net cash used in investing activities

5

-61

-15

-1

-5

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

Cash flows from financing activities:
Cash contributions from Parent Company, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

177

522

Proceeds from issuance of Series A convertible preferred stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

Proceeds from issuance of convertible notes payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

500

Net proceeds from the issuance of common stock

-

-

-

0

-

-

-

932

-

-

-

-

-

12

9,190

64

-

-

-

-

0

0

4

15,647

-

-

Proceeds from the issuance of common stock upon exercise of pre-funded warrants

12

0

17

43

105

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from exercise of stock options

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

Proceeds from the issuance of common stock in connection with the employee stock purchase plan

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

Net cash provided by financing activities

766

-55

18

43

13,390

-68

4,569

932

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

15,644

8,670

1,010

Cash paid in lieu of fractional shares for 1:30 reverse stock split

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

Repayments of capital lease obligations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

2

3

7

12

Net cash provided by financing activities

-

-

-

-

-

-

-

-

-

-

-

-

182

12

9,237

64

-

-

-

-

-

-

-

-

-

-

Net decrease in cash and restricted cash

-

-2,107

-1,930

-2,133

-

-2,075

2,709

-975

-1,835

-2,286

-2,503

-2,701

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net increase (decrease) in cash and cash equivalents

-

-

-

-

-

-

-

-

-

-

-

-

1,082

-1,951

-594

-1,916

3,366

-6,781

2,901

-2,380

4,543

-1,740

-11,056

14,516

7,218

-199

Cash paid for interest

-

-

-

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cash received during the period for interest

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

Cash paid during the period for interest

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

Supplemental disclosure of non-cash investing and financing activities:
Series A and Series A-1 convertible preferred stock dividends

-

-

-

-

-

-

-

-

-

-

-

-

-

-1

22

105

-

-

-

-

-

-

-

-

-

-

Fair value of Series A and Series A-1 convertible preferred stock dividends

-

-

-

-

-

-

-

-

-

-

-

-

0

0

24

185

-

-

-

-

-

-

-

-

-

-

Exchange of convertible preferred stock

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

2,000

-

-

-

-

-

-

-

-

-

-

Exchange of Series A convertible preferred stock into Series A-1 convertible preferred stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

3,000

-

-

-

0

-

-

Right of use asset obtained in exchange for operating lease liability

0

0

0

620

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

Value of Parent Company restricted stock units and common stock issued in lieu of bonuses included in accrued expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

Value of Parent Company restricted stock units issued in lieu of cash bonuses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

Fair value of Parent Company stock options modified

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

Reclassification of derivative liability upon elimination of obligation

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

Fair value of Series A convertible preferred stock beneficial conversion feature

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

Accretion of Series A convertible preferred stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

Conversion of notes payable into Series A convertible preferred stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

Conversions of convertible preferred stock into common stock

-

-

-

-

-

-

-

-

-

-

-

3,525

-

0

3,128

3,686

300

2,557

353

672

-

-

-

0

-

-

Cancellation of notes receivable

-

-

-

-

-

-

-

-

0

0

0

150

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts payable assumed

-

-

-

-

-

-

-

-

0

0

0

5

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Fair value of securities issued

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

Fair value of Parent Company shares mandatorily redeemable for cash upon exercise of warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

Allocation of management expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

Equipment and furnishings exchanged for Parent Company common stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

Fair value of securities issued

-

-

-

-

-

-

-

-

-

-

-

2,737

-

-

-

-

-

-

-

-

-

-

-

0

-

-

Fair value of Series A and Series A-1 convertible preferred stock dividends

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,755

-

-

-

3,547

-

-

Series A and Series A-1 convertible preferred stock dividends

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

114

165

168

-

-

-

170

-

-